3 Biotech Stocks to Avoid Right Now
Did you know that new biotech stocks go public at a rate of about one per week? With so many investment options in this space to choose from, it's a little surprising that some of the most popular companies right now haven't had much success when it comes to drug development.
Every business has a story to tell, and plenty of investors like what they've been hearing from these three. Before following the crowd, though, you should know that there are potholes along these companies' paths to success.
Data source: Yahoo! Finance.
Source Fool.com